Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
Active, not recruiting · NCT04082533 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty) | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Phase 4 | 2026-08-26 | NCT04082533 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospital for Special Surgery, New York | 71 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital for Special Surgery | New York | United States | 106 |